Skip to main content
Clinical Trials/NCT05512624
NCT05512624RecruitingNot Applicable

Integrating an Evidence-based Mental Health Intervention Into Primary Health Care to Improve Outcomes for Refugees With Hypertension, Diabetes, and Epilepsy

International Rescue Committee1 site in 1 country308 target enrollmentStarted: September 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
308
Locations
1
Primary Endpoint
Medication Adherence Report Scale

Study Overview

Brief Summary

The objective of this study is to evaluate the impact of an evidence-based mental health intervention (Common Elements Treatment Approach) on medication adherence, behavioral improvement and clinical outcomesamong adults taking medication for hypertension, diabetes and epilepsy using a two-arm randomized wait-list controlled trial among adult refugees in Mae La camp, Thailand.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •A. Inclusion criteria:
  • •Patients who was diagnosed by physician based on ICD 10 to have diabetes, hypertension or diabetes with hypertension comorbidity, or epilepsy.
  • •Registered in chronic database system of the camp.

Exclusion Criteria

  • •who are younger than 18 years old
  • •who have severe physical illness
  • •who have severe mental disorders
  • •who will not stay in the camp until the end of the program
  • •who are not willing to participate in the program
  • •Exclusion Criteria:

Arms & Interventions

Intervention Arm

Experimental

The course of Common Elements Treatment Approach (CETA - the intervention under study) is built to be flexible depending on need. Mild symptoms could result in fewer sessions (e.g., 5), while greater severity may require 8-12 sessions.

Intervention: Common Elements Treatment Approach (Behavioral)

Waitlisted Arm

No Intervention

The waitlisted arm will be offered the CETA approach upon conclusion of the endline data collection.

Outcomes

Primary Outcomes

Medication Adherence Report Scale

Time Frame: Baseline, Endline, Past two weeks

Medication Adherence - Self Report will be assessed using the 5-item Medication Adherence Report Scale (MARS-5). Each item assesses the frequency of deviations in medication use, ranging from never (0) to all days (4) over the past two weeks. The MARS-5 will be scored by calculating the mean of all items to generate a continuous score ranging from 0-4, with higher scores indicating greater problems with medication adherence.

Pill Count Medication Adherence

Time Frame: Baseline, Endline, Past two weeks

Medication Adherence - Pill Count: Measurement: Medication Adherence will also be objectively measured by counting the proportion of pills taken over the past two weeks relative to the number taken if used as prescribed over the same period. Proportions will range from 0-100% with higher proportion indicating greater adherence. Proportions will be used to classify a binary indicator of adherence using an 80% or higher cutoff.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials